Strategy

Critical Connection: Patient Services and Product Launch

October 14, 2020

A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.

Mastering the Transition From Academia to Industry

October 14, 2020

Tips for rounding out the rough edges in crossover.

Injecting Traditional Scientific Exchange with New Life

October 13, 2020

Female medical affairs leaders speak out with unique perspectives on how MSLs can provide greater value to opinion leaders.

Commercial Sustainability of Pharmaceutical Innovations for Pandemics

September 30, 2020

Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.

Best Practices for Balancing Medical Affairs Globalization with Local Requirements

September 29, 2020

Addressing the challenges faced by Global Medical Affairs teams and how they can find balance to create maximum value for their organizations.

Manage Risk Effectively to Improve the Value of Your Alliance

September 29, 2020

In this article, Eli Lilly & Co. examines risk management in the context of partnerships with other companies.

Planning Ahead for a Post COVID-19 Workforce and Workplace

September 20, 2020

Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.

Drug Launch: Winning the Evidence Battle

September 14, 2020

Beyond necessity and nice-to-have, embracing real-world evidence as a true strategic differentiator.

New Standards for First-to-Launch Players

September 14, 2020

While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.

(O)mega Opportunity: Vascepa

September 14, 2020

Uncovering fish oil derivative’s benefit for heart health.